ABL Bio Inc. (KOSDAQ: 298380)
South Korea
· Delayed Price · Currency is KRW
40,500
+5,400 (15.38%)
Oct 11, 2024, 9:00 AM KST
ABL Bio Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 996.8 | 28,064 | 25,136 | 21,589 |
Short-Term Investments | 814.25 | 8,026 | 7,611 | 74.38 |
Trading Asset Securities | 32,700 | 35,075 | 45,570 | 22,058 |
Cash & Short-Term Investments | 34,511 | 71,165 | 78,317 | 43,721 |
Cash Growth | -61.93% | -9.13% | 79.13% | - |
Other Receivables | 13.37 | 60.89 | 451.78 | 83.87 |
Receivables | 213.37 | 260.89 | 451.78 | 83.87 |
Prepaid Expenses | - | 1,779 | 819.53 | 563.08 |
Other Current Assets | 1,414 | 2,333 | 946.34 | 1,105 |
Total Current Assets | 36,139 | 75,539 | 80,535 | 45,472 |
Property, Plant & Equipment | 79,885 | 76,035 | 6,713 | 3,304 |
Long-Term Investments | 1,707 | 2,743 | 27,634 | 13,503 |
Other Intangible Assets | 2,457 | 2,534 | 2,610 | 2,556 |
Other Long-Term Assets | 523.35 | 3,294 | 67,689 | 617.29 |
Total Assets | 120,711 | 160,144 | 185,181 | 65,453 |
Accrued Expenses | 309.34 | 165.07 | 131.53 | 15.98 |
Current Portion of Leases | 456.39 | 784.47 | 1,167 | 502.03 |
Other Current Liabilities | 22,618 | 40,810 | 70,874 | 8,232 |
Total Current Liabilities | 23,383 | 41,760 | 72,172 | 8,750 |
Long-Term Debt | 43,000 | 43,000 | 40,000 | - |
Long-Term Leases | 15.49 | 153.53 | 668.93 | 72.32 |
Other Long-Term Liabilities | 1,157 | 1,152 | 2,826 | 677.05 |
Total Liabilities | 67,555 | 86,065 | 115,667 | 9,500 |
Common Stock | 24,024 | 23,946 | 23,894 | 23,562 |
Additional Paid-In Capital | 366,410 | 363,760 | 361,173 | 348,732 |
Retained Earnings | -365,725 | -342,345 | -339,134 | -342,535 |
Comprensive Income & Other | 28,447 | 28,718 | 23,580 | 26,194 |
Shareholders' Equity | 53,155 | 74,079 | 69,513 | 55,953 |
Total Liabilities & Equity | 120,711 | 160,144 | 185,181 | 65,453 |
Total Debt | 43,472 | 43,938 | 41,836 | 574.35 |
Net Cash (Debt) | -8,960 | 27,227 | 36,481 | 43,147 |
Net Cash Growth | - | -25.37% | -15.45% | - |
Net Cash Per Share | -187.06 | 569.08 | 766.95 | 918.60 |
Filing Date Shares Outstanding | 48.05 | 47.89 | 47.79 | 47.12 |
Total Common Shares Outstanding | 48.05 | 47.89 | 47.79 | 47.12 |
Working Capital | 12,756 | 33,779 | 8,362 | 36,722 |
Book Value Per Share | 1106.30 | 1546.78 | 1454.61 | 1187.37 |
Tangible Book Value | 50,698 | 71,545 | 66,903 | 53,397 |
Tangible Book Value Per Share | 1055.16 | 1493.87 | 1400.00 | 1133.14 |
Land | 1,286 | 1,194 | 1,173 | - |
Buildings | 1,222 | 1,194 | 1,173 | - |
Machinery | 2,432 | 7,352 | 6,540 | 5,809 |
Construction In Progress | 74,391 | 70,491 | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.